NAL Pharma is a specialty drug developer that develops novel dosage forms and proprietary drug delivery systems based on the Company’s captive Bio-D3, Bio-FX, Bio-CR, Bio-NN, and Bio-MM Drug Delivery System (“DDS”) technologies. For more detailed presentations and discussions, please contact us.
NAL is developing non-infringing, proprietary and improved drug delivery systems that exhibit enhanced patient-compliance, safe...
NAL Pharma is a specialty drug developer that develops novel dosage forms and proprietary drug delivery systems based on the Company’s captive Bio-D3, Bio-FX, Bio-CR, Bio-NN, and Bio-MM Drug Delivery System (“DDS”) technologies. For more detailed presentations and discussions, please contact us.
NAL is developing non-infringing, proprietary and improved drug delivery systems that exhibit enhanced patient-compliance, safety, and/or efficacy compared with existing pharmaceutical products, and is also developing specially designed delivery systems to improve conventional dosage forms of new drugs undergoing Phase 2 clinical development that show significant first-pass metabolism side effects, poor solubility, and poor bioavailability.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.